|
2025 Conference Publication Abstract P5-11-22: Neoadjuvant chemotherapy and survival outcomes in triple-negative breast cancer: a population-based study (Queensland, Australia)Vaz-Goncalves, Larissa, Marquart-Wilson, Louise, Protani, Melinda, Saunus, Jodi, Moore, Julie, Morris, Michelle and Reeves, Marina (2025). Abstract P5-11-22: Neoadjuvant chemotherapy and survival outcomes in triple-negative breast cancer: a population-based study (Queensland, Australia). San Antonio Breast Cancer Symposium 2024, San Antonio, TX, United States, 10-13 December 2024. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1557-3265.sabcs24-p5-11-22 |
|
2024 Conference Publication Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohortVaz-Goncalves, Larissa, Marquart-Wilson, Louise, Protani, Melinda M., Saunus, Jodi M., Moore, Julie, Morris, Michelle J. and Reeves, Marina M. (2024). Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Investigating survival by breast cancer molecular subtype in Australia: A population-based studyVaz-Goncalves, L., Marquart-Wilson, L., Protani, M., Stephensen, M., Saunus, J., Moore, J., Morris, M. and Reeves, M. (2024). Investigating survival by breast cancer molecular subtype in Australia: A population-based study. ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.237 |
